International Congress on Neurodegenerative Diseases

19th - 21st SEPTEMBER 2024| LISBOA

REGISTRATION
POSTERS SUBMISSION
COVER PICTURE: Dancing Astrocytes

ABOUT US

Lisboa

The International Congress on Neurodegenerative Diseases will be held in Lisbon, Portugal for another year under the presidency of H.M. Queen Sofia, from 18 to 21 September to coincide and celebrate International Alzheimer's Day.

These meetings have been organised since 2013 by the Queen Sofia Foundation together with the CIEN Foundation. This year, it will be also be with close collaboration with the Champalimaud Foundation, as in the Alzheimer´s Global Summit held in 2017.

As in previous years, this scientific Congress aims to bring advances in research in the fight against Alzheimer's and other neurodegenerative diseases to the public, and above all, to raise awareness to advance the search for global solutions and responses due to their social consequences. The International Congress on Neurodegenerative Diseases will focus on advances in research into neurodegenerative disorders. It will provide a forum to discuss a range of areas of interest related to basic, clinical and translational aspects of neurodegenerative disease research, providing researchers from around the world with the opportunity to discuss and share experiences and to be engaged by topics that extend into the future and that will be vital in advancing the understanding and treatment of these diseases.

This year's program is structured into VII scientific sessions of exceptional quality, with the participation of more than thirty researchers and representatives of associations from several countries.

A must-attend event for neurodegenerative disease research professionals!

PROGRAM

INTERNATIONAL CONGRESS ON NEURODEGENERATIVE DISEASES


Early detection of the pathological components leading to cognitive deterioration
8:30 – 9:00
Lecture
Registration
9:00 - 11:30
Conference
Scientific Session I: Neuropathology

We will start with a neuropathology session proposing that co-pathology is the norm in dementia, and most patients have several components: tau, amyloid, tdp43, alpha-synuclein.


CHAIRPERSON: Alberto Rábano . BTCIEN-Fundación CIEN.

Sandra Oliveira Tomé . KU-Leuven

“Title”

Gabor Kovacs . Laboratory Medicine & Pathobiology. University of Toronto. (On-line)

“Title”

Diego Sepúlveda . UKE Hamburgh

“Title”

Ed Lein . Allen Institute, Seattle

“Single cell transcriptomics & disease progression in Alzheimer's Disease”

11:30 - 12:00
Conference
Break & posters
12:00 – 13:00
Cofee
Scientific Session II: Genetic variability

In the following session, we will address how genetic variability is associated with the risk of AD and some of the most frequent co-pathologies (alpha-synuclein, TDP43, vascular…) and how it can potentially be used for diagnostic and/or risk classification. We will also explore brain resilience from a genetic perspective.

CHAIRPERSON: Agustín Ruiz Fundació ACE-CIBERNED

Agustín Ruiz. Fundació ACE-CIBERNED

“Title”

Alfredo Ramírez . Cluster of Excellence for Aging Research. University of Cologne.

“Title”

Henne Holstege . Alzheimer Center Amsterdam. VUmc. Amsterdam UMC

“Title”

13:00 - 15:00
Coffee
Lunch & posters
15:00 - 16:30
Cofee
SCIENTIFIC SESSION III: Neuroimaging

We will deepen into neuroimaging techniques for detecting different dementia-related brain alterations reflecting distinct pathologic components.

CHAIRPERSON: Michel Grothe. Fundación CIEN

David Wolk , Laboratory for Cognition and Neural Stimulation. University of Pennsylvania

"Title"

Jesús Silva. , Fundación CIEN
"Title"

Laura Jonkman, Amsterdam Neuroscience - Brain Imaging (VUmc). Amsterdam UMC

"Title"

16:30 - 17:00
Coffee
Coffee break & posters
17:00-18:30
Cofee
SCIENTIFIC SESSION IV: Biomarkers

Discussing the detection of neuropathological components in the periphery using biochemical markers.

CHAIRPERSON: Pascual Sánchez Juan Fundación CIEN

Gemma Salvadó . Clinical Memory Research. Lund University

"Title"

Anja Schneider. Translational Dementia Research. German Center for Neurodegenerative Diseases-DZNE. University of Bonn.

"Title"

Marc Suarez . Barcelona Beta Brain Research.

"Title"

VENUE

Fundação Champalimaud
Fundação Champalimaud

Fundação Champalimaud.

¿Cómo llegar?

Av. Brasília, 1400-038. Lisbon, Portugal.

CONTACT

Ministerio de Sanidad, Servicios Sociales e Igualdad Instituto de Mayores y Servicios Sociales CRE Alzheimer Salamanca Ministerio de Ciencia Instituto de Salud Carlos III